<DOC>
	<DOCNO>NCT01817803</DOCNO>
	<brief_summary>To compare effectiveness safety diuretic add-on strategy chronic heart failure patient</brief_summary>
	<brief_title>A Prospective , Single-center , Open-label , Pilot Study Compare Effectiveness Safety Diuretics Add-On Strategy Chronic Heart Failure Patients ( DIOS 1 )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Metolazone</mesh_term>
	<criteria>1. dyspnea rest minimal activity 2. tachypnea ( respiratory rate &gt; 20/min ) rale pulmonary edema chest Xray 3. need diuretic add 40mg daily furosemide dose 1 . Hospitalization acute heart failure decompensation 2. cardiogenic shock ( Systolic Blood Pressure &lt; 80mmHg ) 3 . Need plan renal replacement therapy ( dialysis , kidney transplant ) 4. serum creatine level &gt; 2.5mg/dl 5. serum potassium ( K+ ) &gt; 5.5mg/dl 6. daily spironolactone dose &gt; 50mg 7. previous thiazide metolazone user 8 . Age &gt; 75 year old poor compliance patient 9. allergy , adverse drug reaction , hypersensitivity kind diuretic 10. life expectancy &lt; 6 month ( e.g . metastatic malignancy , liver cirrhosis ) 11. pregnancy woman age childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>diuretic</keyword>
	<keyword>kidney</keyword>
	<keyword>glomerular filtration rate</keyword>
</DOC>